Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥87.49B | ¥65.73B | ¥55.62B | ¥49.27B | ¥36.14B | ¥16.26B | ¥7.82B | ¥4.95B | ¥0 | ¥0 |
| Gross profit | ¥11.92B | ¥6.49B | ¥3.05B | ¥5.14B | ¥6.82B | ¥1.87B | −¥1.20B | −¥255.9M | — | — |
| Research & development | ¥10.60B | ¥13.04B | ¥13.43B | ¥10.84B | ¥4.59B | ¥2.49B | ¥4.43B | ¥4.00B | ¥2.60B | ¥1.47B |
| Operating expenses | ¥25.96B | ¥28.37B | ¥25.71B | ¥20.78B | ¥11.32B | ¥6.48B | ¥9.88B | ¥9.34B | ¥4.95B | ¥2.60B |
| Operating income | −¥14.04B | −¥21.87B | −¥22.66B | −¥15.64B | −¥4.50B | −¥4.61B | −¥11.08B | −¥9.60B | −¥4.95B | −¥2.60B |
| EBITDAderived | −¥6.89B | −¥16.00B | −¥19.28B | −¥12.79B | −¥2.79B | −¥3.56B | −¥10.08B | −¥9.12B | −¥4.79B | −¥2.56B |
| Net income | −¥14.94B | −¥22.40B | −¥20.72B | −¥14.44B | −¥4.02B | −¥5.30B | −¥11.30B | −¥9.64B | −¥5.02B | −¥2.57B |
| Basic EPSper diluted share | -CN¥6.85 | -CN¥11.03 | -CN¥12.44 | -CN¥8.89 | -CN¥6.72 | -CN¥4.74 | -CN¥11.08 | -CN¥70.23 | -CN¥346.84 | -CN¥210.66 |
| Diluted EPSper diluted share | -CN¥6.85 | -CN¥11.03 | -CN¥12.44 | -CN¥8.89 | -CN¥6.72 | -CN¥4.74 | -CN¥11.08 | -CN¥70.23 | -CN¥346.84 | -CN¥210.66 |